This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Osaka Gas Company Limited, National Institute of Advanced Industrial Science and Technology. Active years: 1994-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ikoma, JP (1994)
- Osaka, JP (2019)
Company Filing History:


Years Active: 1994-2019
Title: Isao Matsushita: Innovator in Biotechnology
Introduction
Isao Matsushita is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of processes and antibodies that have practical applications in medical science. With a total of 2 patents, Matsushita's work exemplifies innovation and dedication to advancing technology.
Latest Patents
Matsushita's latest patents include a process for producing 3-hydroxybutyric acid or a salt thereof. This process involves culturing one or more halophilic bacteria belonging to the genus under specific conditions. Additionally, he has developed a monoclonal antibody that specifically recognizes the N-terminal portion of human calcitonin (hCT). This hybridoma produces the monoclonal antibody, which is crucial for detecting hCT with high sensitivity.
Career Highlights
Throughout his career, Matsushita has worked with prominent organizations such as Osaka Gas Company Limited and the National Institute of Advanced Industrial Science and Technology. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking research in biotechnology.
Collaborations
Matsushita has collaborated with notable colleagues, including Nobuhiko Yamashita and Manabu Nakamoto. These partnerships have fostered an environment of innovation and have led to significant advancements in their respective fields.
Conclusion
Isao Matsushita's contributions to biotechnology through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of medical technologies that benefit society.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile